Absci Corporation (ABSI)

3d ago, source: Yahoo Finance

VANCOUVER, Wash. and NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report ...

Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?

15d ago, source: Hosted on MSN

Absci Corporation (ABSI) shares rallied 16.8% in the last trading session to close at $6.59. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May ...

9d ago, source: The Bakersfield Californian

Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates ...

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

1mon ago, source: Business Insider

and NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results for the fourth ...

Absci (NASDAQ: ABSI)

6d ago, source: The Motley Fool

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech ...

Buy Rating Affirmed for AbSci: Promising Pipeline and Strategic Partnerships Signal Growth

1mon ago, source: Business Insider

Begin your TipRanks Premium journey today. AbSci (ABSI) Company Description: Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the ...

Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?

1mon ago, source: Zacks.com on MSN

Absci Corporation (ABSI) shares rallied 10% in the last trading session to close at $5.16. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

Absci Corp.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Absci Announces Proposed Public Offering of Common Stock

20d ago, source: ADVFN

Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, announced today that it has commenced an underwritten public offering of $75.0 million of shares ...